System-based approaches to decode the molecular links in Parkinson's disease and diabetes

A growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share rem...

Full description

Bibliographic Details
Main Authors: Jose A. Santiago, Judith A. Potashkin
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996114000801
id doaj-76aba73f4d184316a59bc7df520c4fb9
record_format Article
spelling doaj-76aba73f4d184316a59bc7df520c4fb92021-03-22T12:41:08ZengElsevierNeurobiology of Disease1095-953X2014-12-01728491System-based approaches to decode the molecular links in Parkinson's disease and diabetesJose A. Santiago0Judith A. Potashkin1The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USACorresponding author at: Department of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.; The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USAA growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share remarkably similar dysregulated pathways. It has been proposed that a cascade of events including mitochondrial dysfunction, impaired insulin signaling, and metabolic inflammation trigger neurodegeneration in T2DM models. Network-based approaches have elucidated a potential molecular framework linking both diseases. Further, transcriptional signatures that modulate the neurodegenerative phenotype in T2DM have been identified. Here we contextualize the current experimental approaches to dissect the mechanisms underlying the association between PD and T2DM and discuss the existing challenges toward the understanding of the coexistence of these devastating aging diseases.http://www.sciencedirect.com/science/article/pii/S0969996114000801Parkinson's diseaseType 2 diabetesNeurodegenerationInflammationInsulin resistance
collection DOAJ
language English
format Article
sources DOAJ
author Jose A. Santiago
Judith A. Potashkin
spellingShingle Jose A. Santiago
Judith A. Potashkin
System-based approaches to decode the molecular links in Parkinson's disease and diabetes
Neurobiology of Disease
Parkinson's disease
Type 2 diabetes
Neurodegeneration
Inflammation
Insulin resistance
author_facet Jose A. Santiago
Judith A. Potashkin
author_sort Jose A. Santiago
title System-based approaches to decode the molecular links in Parkinson's disease and diabetes
title_short System-based approaches to decode the molecular links in Parkinson's disease and diabetes
title_full System-based approaches to decode the molecular links in Parkinson's disease and diabetes
title_fullStr System-based approaches to decode the molecular links in Parkinson's disease and diabetes
title_full_unstemmed System-based approaches to decode the molecular links in Parkinson's disease and diabetes
title_sort system-based approaches to decode the molecular links in parkinson's disease and diabetes
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2014-12-01
description A growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share remarkably similar dysregulated pathways. It has been proposed that a cascade of events including mitochondrial dysfunction, impaired insulin signaling, and metabolic inflammation trigger neurodegeneration in T2DM models. Network-based approaches have elucidated a potential molecular framework linking both diseases. Further, transcriptional signatures that modulate the neurodegenerative phenotype in T2DM have been identified. Here we contextualize the current experimental approaches to dissect the mechanisms underlying the association between PD and T2DM and discuss the existing challenges toward the understanding of the coexistence of these devastating aging diseases.
topic Parkinson's disease
Type 2 diabetes
Neurodegeneration
Inflammation
Insulin resistance
url http://www.sciencedirect.com/science/article/pii/S0969996114000801
work_keys_str_mv AT joseasantiago systembasedapproachestodecodethemolecularlinksinparkinsonsdiseaseanddiabetes
AT judithapotashkin systembasedapproachestodecodethemolecularlinksinparkinsonsdiseaseanddiabetes
_version_ 1724208356153884672